Clostridium bacteraemia characterised by 16S ribosomal RNA gene sequencing

被引:44
作者
Woo, PCY [1 ]
Lau, SKP [1 ]
Chan, KM [1 ]
Fung, AMY [1 ]
Tang, BSF [1 ]
Yuen, KY [1 ]
机构
[1] Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China
关键词
D O I
10.1136/jcp.2004.022830
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Owing to problems in accurate species identification of the diverse genus clostridium, the epidemiology and pathogenicity of many species are not fully understood. Moreover, previous studies on clostridium bacteraemia have been limited and relied only on phenotypic species identification. Aims: To characterise the epidemiology, disease spectrum, and outcome of clostridium bacteraemia using 16S ribosomal RNA ( rRNA) gene sequencing. Method: During a four year period ( 1998 - 2001), all cases of clostridium bacteraemia were prospectively studied and all "non-perfringens'' clostridium isolates identified to the species level by 16S rRNA gene sequencing. Results: Fifty one blood culture isolates were identified as Clostridium perfringens and 17 belonged to 11 other clostridium species. The first case of C disporicum infection and two cases of clostridium bacteraemia in children with intussusception were also described. Of the 68 clostridium isolates from 68 different patients, 38 were associated with clinically relevant bacteraemia. The gastrointestinal and hepatobiliary tracts were common sites of both underlying disease and portal of entry in these patients. Clostridium perfringens accounted for 79% of all clinically relevant bacteraemia, with the remainder caused by a diversity of species. The attributable mortality rate of clinically relevant clostridium bacteraemia was 29%. Younger age and underlying gastrointestinal/ hepatobiliary tract disease were associated with mortality ( p< 0.05). Conclusions: Patients with clinically relevant clostridium bacteraemia should be investigated for the presence of underlying disease processes in the gastrointestinal or hepatobiliary tracts. 16S rRNA gene analysis will continue to be useful in further understanding the pathogenicity of various clostridium species.
引用
收藏
页码:301 / 307
页数:7
相关论文
共 19 条
[11]   Clinical features of clostridial bacteremia: A review from a rural area [J].
Rechner, PM ;
Agger, WA ;
Mruz, K ;
Cogbill, TH .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (03) :349-353
[12]   IDENTIFICATION OF THE UNCULTURED BACILLUS OF WHIPPLES DISEASE [J].
RELMAN, DA ;
SCHMIDT, TM ;
MACDERMOTT, RP ;
FALKOW, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (05) :293-301
[13]   THE AGENT OF BACILLARY ANGIOMATOSIS - AN APPROACH TO THE IDENTIFICATION OF UNCULTURED PATHOGENS [J].
RELMAN, DA ;
LOUTIT, JS ;
SCHMIDT, TM ;
FALKOW, S ;
TOMPKINS, LS .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (23) :1573-1580
[14]   Characterization of novel psychrophilic clostridia from an Antarctic microbial mat:: description of Clostridium frigoris sp nov., Clostridium lacusfryxellense sp nov., Clostridium bowmanii sp nov and Clostridium psychrophilum sp nov and reclassification of Clostridium laramiense as Clostridium estertheticum subsp laramiense subsp nov. [J].
Spring, S ;
Merkhoffer, B ;
Weiss, N ;
Kroppenstedt, RM ;
Hippe, H ;
Stackebrandt, E .
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, 2003, 53 :1019-1029
[15]  
Stackebrandt E, 1999, FEMS IMMUNOL MED MIC, V24, P253, DOI 10.1016/S0928-8244(99)00039-5
[16]   Reclassification of Clostridium quercicolum as Dendrosporobacter quercicolus gen. nov., comb. nov. [J].
Strömpl, C ;
Tindall, BJ ;
Lünsdorf, H ;
Wong, TY ;
Moore, ERB ;
Hippe, H .
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, 2000, 50 :101-106
[17]   CLUSTAL-W - IMPROVING THE SENSITIVITY OF PROGRESSIVE MULTIPLE SEQUENCE ALIGNMENT THROUGH SEQUENCE WEIGHTING, POSITION-SPECIFIC GAP PENALTIES AND WEIGHT MATRIX CHOICE [J].
THOMPSON, JD ;
HIGGINS, DG ;
GIBSON, TJ .
NUCLEIC ACIDS RESEARCH, 1994, 22 (22) :4673-4680
[18]  
Weinstein MP, 1997, CLIN INFECT DIS, V24, P584, DOI 10.1093/clind/24.4.584
[19]   Laribacter hongkongensis gen. nov., sp nov., a novel gram-negative bacterium isolated from a cirrhotic patient with bacteremia and empyema [J].
Yuen, KY ;
Woo, PCY ;
Teng, JLL ;
Leung, KW ;
Wong, MKM ;
Lau, SKP .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (12) :4227-4232